TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
Description
CONCLUSION: TNF inhibitors significantly reduce the humoral response following dual vaccination against COVID-19 in patients with RA.
